Clinical trials
Active, not recruiting trials in Botswana
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Harvard School of Public Health (HSPH) | 2 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 1 |
| Brigham and Women's Hospital | 1 |
| Massachusetts General Hospital | 1 |
| University of California, San Diego | 1 |
| ViiV Healthcare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 4 |
| HIV Infections | 3 |
| Uterine Cervical Neoplasms | 2 |
| Anus Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Neoplasms | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Stroke | 1 |
| Tuberculosis | 1 |
| Tuberculosis, Multidrug-Resistant | 1 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.